PharmaCyte Biotech Inc (PMCB)

[frosr6]

DRI already curing T1 diabetes. Beat pmcb oh by 20 years.

?After receiving a call from the DRI's Clinical Cell Transplant Team, Wendy Peacock became the first patient transplanted in our FDA-approved Phase I/II clinical trial to test the omentum as a new implant site for a DRI BioHub, a bioengineered “mini-organ” that mimics the native pancreas to restore natural insulin production in people with type 1 diabetes. Within days after the transplant procedure, Wendy was able to discontinue insulin therapy, as she began producing insulin on her own for the first time since being diagnosed with type 1 diabetes. Read the News Release>??In this first-ever clinical trial, researchers will evaluate whether the omentum is a better home for the islets than the liver, the traditional transplant site. The donor islet cells were implanted using a biologic, fully re-absorbable scaffold technique - referred to as a "biodegradable scaffold," one of the DRI BioHub platforms. This scaffold is a combination of the patient's own plasma, the liquid part of the blood that does not contain any cells, together with thrombin, a commonly-used, clinical-grade enzyme. ??The DRI's preliminary findings have shown that islets in the omentum can survive and function long term. This clinical trial is an important first step in identifying an optimal location in the body for a DRI BioHub.